Literature DB >> 6374884

[Initial experiences with the calcium antagonist tiapamil in the treatment of arterial hypertension].

F Rhomberg, K Bachmann, H Bächtold, P Müller.   

Abstract

24 hypertensive patients were treated with 300-450 mg tiapamil daily for 2-6 months. The antihypertensive effect of this new calcium entry blocking agent was expressed by a reduction even of extremely elevated blood pressures to the normotensive, but not to the hypotensive range, in 20 patients. The drug was well tolerated.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6374884

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN： 0036-7672


  3 in total

1.  Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension.

Authors:  P Omvik; P Lund-Johansen
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

2.  Excretion of tiapamil in breast milk.

Authors:  D Hartmann; N O Lunell; G Friedrich; A Rane
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

3.  Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis.

Authors:  P H Hinderling; M Eckert; S Gasic; H G Eichler; R Pötzi; P Heizmann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.